Publications:

Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers.

Protein & Cell

Ge, Yuanlong Y; Wu, Shu S; Zhang, Zepeng Z; Li, Xiaocui X; Li, Feng F; Yan, Siyu S; Liu, Haiying H; Huang, Junjiu J; Zhao, Yong Y

Publication Date: 2019-11

Variant appearance in text: p53: s269e

PubMed Link: 31115790

Variant Present in the following documents:

• Main text
• 13238_2019_Article_634.pdf

View BVdb publication page

Aurora B interacts with NIR-p53, leading to p53 phosphorylation in its DNA-binding domain and subsequent functional suppression.

The Journal Of Biological Chemistry

Wu, Liming L; Ma, Chi A CA; Zhao, Yongge Y; Jain, Ashish A

Publication Date: 2011-01-21

Variant appearance in text: p53: S269E

PubMed Link: 20959462

Variant Present in the following documents:

• Main text

View BVdb publication page

Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localization.

Biochemical And Biophysical Research Communications

An, Rong R; da Silva Xavier, Gabriela G; Semplici, Francesca F; Vakhshouri, Saharnaz S; Hao, Huai-Xiang HX; Rutter, Jared J; Pagano, Mario A MA; Meggio, Flavio F; Pinna, Lorenzo A LA; Rutter, Guy A GA

Publication Date: 2010-08-20

Variant appearance in text: p53: S269E

PubMed Link: 20637728

Variant Present in the following documents:

• Main text

View BVdb publication page